Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT1RB vs ACEi +/- Allopurinol in Diabetic Acute MI
NCT01052272Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2005
- Primary completion
- Nov 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan cilexetil, allopurinol in myocardial infarction (MI), heart failure (HF), sponsored by University of Alabama at Birmingham. Started Jul 2005; status: completed.
02
Drugs
candesartan cilexetilallopurinol
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on NCT01052272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052272.